Cathepsin V is a useful prognostic factor for colorectal cancer.

Cathepsin V Colorectal cancer Prognosis Survival

Journal

Pathology, research and practice
ISSN: 1618-0631
Titre abrégé: Pathol Res Pract
Pays: Germany
ID NLM: 7806109

Informations de publication

Date de publication:
14 Aug 2024
Historique:
received: 18 03 2024
revised: 09 08 2024
accepted: 10 08 2024
medline: 18 8 2024
pubmed: 18 8 2024
entrez: 17 8 2024
Statut: aheadofprint

Résumé

Molecular studies have identified various treatment-related prognostic molecules to enhance the effectiveness of colorectal cancer (CRC) treatment and improve survival rates. The expression of cathepsin V in gastrointestinal cancer cells prompted an investigation into its potential as a prognostic indicator for CRC. The evaluation of cathepsin V expression and its clinicopathological significance was conducted through immunohistochemistry in a tissue microarray, encompassing 142 CRC and normal colorectal tissues. Overall and disease-free survival rates, based on cathepsin V expression levels, were assessed using the Kaplan-Meier method and compared utilizing the log-rank test. Univariate and multivariate analyses, employing a Cox proportional hazards model, were performed to identify prognostic factors. Cathepsin V expression exhibited no correlation with age, sex, tumor location, tumor size, or histological grade. However, it was significantly correlated with depth of tumor invasion, regional lymph node (LN) metastasis, distant metastasis, and lymphovascular involvement (all p<0.001). Overall and disease-free survival rates were significantly better with low cathepsin V expression than with high expression (p<0.001). Univariate analysis identified several prognostic factors, including histological grade (low vs. high), tumor size (≤ vs. >5 cm), tumor depth (T1 vs. ≥T2), regional LN metastasis, distant metastasis, tumor-node-metastasis (TNM) stage (Stage I vs ≥II), lymphovascular involvement, and cathepsin V expression. Multivariate analysis revealed that tumor depth, distant metastasis, and cathepsin V expression are independent predictors of poor survival. Cathepsin V is frequently expressed in CRC, and its high expression is associated with poor prognosis. Therefore, cathepsin V is a useful prognostic marker for CRC.

Identifiants

pubmed: 39153237
pii: S0344-0338(24)00442-4
doi: 10.1016/j.prp.2024.155531
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

155531

Informations de copyright

Copyright © 2024. Published by Elsevier GmbH.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Moon-Soo Lee (MS)

Department of Surgery, Eulji Medical Center, Daejeon, Republic of Korea.

Chang-Nam Kim (CN)

Department of Surgery, Eulji Medical Center, Daejeon, Republic of Korea.

Dong Wook Kang (DW)

Department of Pathology, Eulji Medical Center, Daejeon, Republic of Korea.

Joo Heon Kim (JH)

Department of Pathology, Eulji Medical Center, Daejeon, Republic of Korea. Electronic address: kjh2000@eulji.ac.kr.

Classifications MeSH